HUP0204180A2 - Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére - Google Patents

Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére

Info

Publication number
HUP0204180A2
HUP0204180A2 HU0204180A HUP0204180A HUP0204180A2 HU P0204180 A2 HUP0204180 A2 HU P0204180A2 HU 0204180 A HU0204180 A HU 0204180A HU P0204180 A HUP0204180 A HU P0204180A HU P0204180 A2 HUP0204180 A2 HU P0204180A2
Authority
HU
Hungary
Prior art keywords
treating
skin diseases
external composition
allergic skin
treatment
Prior art date
Application number
HU0204180A
Other languages
English (en)
Inventor
Yukiko Amoto
Shin-Ichi Hisaichi
Seiichiro Kawabata
Mitsuhiro Kawata
Daisuke Nakayama
Masaaki Tokuda
Original Assignee
Teikoku Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co., Ltd. filed Critical Teikoku Seiyaku Co., Ltd.
Publication of HUP0204180A2 publication Critical patent/HUP0204180A2/hu
Publication of HUP0204180A3 publication Critical patent/HUP0204180A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Abstract

A találmány allergiás dermatitisz kezelésére szolgáló külsőlegesgyógyszerkészítményekre vonatkozik, amelyek hatóanyagként kizárólagaszpirint tartalmaznak, és amelyeknek kiváló terápiás hatásuk van,elhanyagolható mellékhatások mellett; továbbá egy eljárásra atalálmány szerinti gyógyszerkészítmények külsőleges alkalmazásáraallergiás dermatitisz kezelésére. Ó
HU0204180A 1999-12-28 2000-12-15 External composition and its use for treating of allergic skin diseases HUP0204180A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37355199A JP2001187739A (ja) 1999-12-28 1999-12-28 アレルギー性皮膚疾患治療用外用剤
PCT/JP2000/008889 WO2001047526A1 (fr) 1999-12-28 2000-12-15 Medicaments a usage externe pour manifestations allergiques de la peau

Publications (2)

Publication Number Publication Date
HUP0204180A2 true HUP0204180A2 (hu) 2003-04-28
HUP0204180A3 HUP0204180A3 (en) 2003-05-28

Family

ID=18502360

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204180A HUP0204180A3 (en) 1999-12-28 2000-12-15 External composition and its use for treating of allergic skin diseases

Country Status (14)

Country Link
US (1) US20030125307A1 (hu)
EP (1) EP1256346A4 (hu)
JP (1) JP2001187739A (hu)
KR (1) KR20020068386A (hu)
CN (1) CN1414855A (hu)
AU (1) AU779624B2 (hu)
CA (1) CA2394393A1 (hu)
HU (1) HUP0204180A3 (hu)
IL (1) IL150122A0 (hu)
MX (1) MXPA02006448A (hu)
NO (1) NO20023110D0 (hu)
NZ (1) NZ519784A (hu)
WO (1) WO2001047526A1 (hu)
ZA (1) ZA200204625B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
JP4791682B2 (ja) * 2003-02-21 2011-10-12 帝國製薬株式会社 痔疾患用治療剤
JP2004262776A (ja) * 2003-02-21 2004-09-24 Teikoku Seiyaku Co Ltd 血管新生促進剤
EP1716854A4 (en) * 2004-02-16 2010-01-20 Teikoku Seiyaku Kk EXTERNAL PREPARATION FOR TREATING PAINFUL SKIN WOUNDS
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
JPS52136922A (en) * 1976-01-01 1977-11-16 Wellcome Found Antiiallergy medical composition
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
JP3040427B2 (ja) * 1989-05-18 2000-05-15 帝國製薬株式会社 神経痛治療用アスピリン含有軟膏組成物
US5223267A (en) * 1989-05-30 1993-06-29 Purepac, Inc. Analgesic compositions
US4975269A (en) * 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
JP3554573B2 (ja) * 1992-06-30 2004-08-18 積水化学工業株式会社 アスピリン含有経皮吸収製剤
JPH08208487A (ja) * 1995-02-01 1996-08-13 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
DE69635298T2 (de) * 1995-12-26 2006-07-13 Teikoku Seiyaku K.K. Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
US5932230A (en) * 1997-05-20 1999-08-03 Degrate; Frenchell Topical analgesic formulation containing fruits, oils and aspirin
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤

Also Published As

Publication number Publication date
MXPA02006448A (es) 2003-09-22
CA2394393A1 (en) 2001-07-05
KR20020068386A (ko) 2002-08-27
NZ519784A (en) 2005-05-27
WO2001047526A1 (fr) 2001-07-05
ZA200204625B (en) 2003-01-16
NO20023110L (no) 2002-06-27
JP2001187739A (ja) 2001-07-10
NO20023110D0 (no) 2002-06-27
HUP0204180A3 (en) 2003-05-28
US20030125307A1 (en) 2003-07-03
EP1256346A1 (en) 2002-11-13
CN1414855A (zh) 2003-04-30
AU779624B2 (en) 2005-02-03
IL150122A0 (en) 2002-12-01
EP1256346A4 (en) 2006-03-22
AU1890801A (en) 2001-07-09

Similar Documents

Publication Publication Date Title
AU2002233288A1 (en) Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
IL139230A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear
HUP0300426A2 (hu) Antihipertenzív és anti-angiogén szerek terápiás kombinációja és ezeket tartalmazó gyógyszerkészítmények
WO2002085299A3 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
DK1343472T3 (da) Thixotropisk næsespray
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
HUP0203321A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrug készítmények gyulladás kezelésére
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
ATE241640T1 (de) Fusidinsäure-derivate
BR0212274A (pt) Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma
PT1150981E (pt) Composto nucleosidico terapeutico

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees